LLY

726.05

0%↓

UNH

513.46

+0.8%↑

JNJ

146.98

0%↓

ABBV

171.37

0%↓

NVO

79.57

+1.07%↑

LLY

726.05

0%↓

UNH

513.46

+0.8%↑

JNJ

146.98

0%↓

ABBV

171.37

0%↓

NVO

79.57

+1.07%↑

LLY

726.05

0%↓

UNH

513.46

+0.8%↑

JNJ

146.98

0%↓

ABBV

171.37

0%↓

NVO

79.57

+1.07%↑

LLY

726.05

0%↓

UNH

513.46

+0.8%↑

JNJ

146.98

0%↓

ABBV

171.37

0%↓

NVO

79.57

+1.07%↑

LLY

726.05

0%↓

UNH

513.46

+0.8%↑

JNJ

146.98

0%↓

ABBV

171.37

0%↓

NVO

79.57

+1.07%↑

Search

Apellis Pharmaceuticals Inc

Cerrado

Sector Salud

27.65 -3.15

Resumen

Variación precio

24h

Actual

Mínimo

27.65

Máximo

29.12

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+60.71 upside

Dividendos

By Dow Jones

Próximas Ganancias

25 feb 2025

Noticias sobre sentimiento de mercado

By Acuity

29%

71%

86 / 392 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Apellis Pharmaceuticals Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

14 ene 2025, 18:52 UTC

Principales Movimientos del Mercado

Cannabis Stocks Pull Back After DEA Postpones Rescheduling Hearings

14 ene 2025, 23:28 UTC

Principales Noticias

South Korea Jobless Rate at Over Three-Year High in December

14 ene 2025, 22:00 UTC

Principales Noticias

Justin Trudeau Is Leaving a Job No One Seems to Want, Except Mark Carney -- WSJ

14 ene 2025, 21:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

14 ene 2025, 21:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

14 ene 2025, 21:29 UTC

Adquisiciones, fusiones, absorciones

TikTok Ban: China Reportedly Mulls Musk As TikTok Buyer. What Would It Cost? -- IBD

14 ene 2025, 21:24 UTC

Principales Noticias

KKR Faces $650 Million DOJ Lawsuit Over Allegations of Improper Premerger Filings -- Update

14 ene 2025, 21:22 UTC

Principales Noticias

Stocks Wobble After PPI Data -- WSJ

14 ene 2025, 21:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

14 ene 2025, 20:45 UTC

Charlas de Mercado

Front-Month Gold Rises on Cautious Optimism -- Market Talk

14 ene 2025, 20:29 UTC

Charlas de Mercado

Oil Futures Retreat From Sanctions-Driven Highs -- Market Talk

14 ene 2025, 20:26 UTC

Principales Noticias

Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says -- 2nd Update

14 ene 2025, 20:22 UTC

Charlas de Mercado

U.S. Natural Gas Futures Turn Higher on Colder Forecasts -- Market Talk

14 ene 2025, 20:16 UTC

Principales Noticias

BlackRock Executive Seen as Leading CEO Contender to Leave Firm -- Update

14 ene 2025, 20:10 UTC

Charlas de Mercado

Canadian Telecoms Face Squeeze as Government Axes Growth Plans -- Market Talk

14 ene 2025, 19:38 UTC

Principales Noticias

BlackRock Executive Seen As a Leading CEO Contender To Leave Firm -- WSJ

14 ene 2025, 19:16 UTC

Principales Noticias

Stocks Wobble After PPI Data -- WSJ

14 ene 2025, 19:14 UTC

Principales Noticias

Boeing Stock Is Dropping on December Deliveries. This Number Was Crucial. -- Barrons.com

14 ene 2025, 18:45 UTC

Principales Noticias

Former Wells Fargo Execs Fined for Role in Fraudulent Bank Accounts

14 ene 2025, 18:31 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

14 ene 2025, 18:31 UTC

Charlas de Mercado

Commodities Strengthen on Positioning for Trump Policies -- Market Talk

14 ene 2025, 18:26 UTC

Principales Noticias

Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says -- Update

14 ene 2025, 18:26 UTC

Charlas de Mercado

Fiserv's Best Days Are Ahead Even After Strong Earnings Run -- Market Talk

14 ene 2025, 18:01 UTC

Ganancias

These Stocks Are Moving the Most Today: Palantir, Nvidia, Eli Lilly, Boeing, KB Home, Signet, Aehr, and More -- Barrons.com

14 ene 2025, 17:51 UTC

Adquisiciones, fusiones, absorciones

Snap and Meta Stocks Fall as TikTok Attracts Last-Minute Takeover Talk -- Barrons.com

14 ene 2025, 17:33 UTC

Adquisiciones, fusiones, absorciones

CN: Decision Allows CN to Combine IANR's 175 Route Miles With CN's Network as Early as Feb. 13

14 ene 2025, 17:31 UTC

Adquisiciones, fusiones, absorciones

CN's Acquisition of Iowa Northern Approved by STB

14 ene 2025, 17:31 UTC

Principales Noticias

KKR Faces $650M DOJ Lawsuit Over Allegations of Improper Pre-Merger Filings

14 ene 2025, 17:25 UTC

Principales Noticias

Meta to Cut 5% of Staff as Mark Zuckerberg Says He Will 'Raise The Bar' -- WSJ

14 ene 2025, 17:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Apellis Pharmaceuticals Inc Esperado

Precio Objetivo

By TipRanks

60.71% repunte

Estimación a 12 meses

Media 44.5 USD  60.71%

Máximo 60 USD

Mínimo 26 USD

De acuerdo con 19 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Apellis Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

19 ratings

12

Comprar

7

Mantener

0

Vender

Puntuación técnica

By Trading Central

59.71 / 72.47Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

86 / 392 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

$